4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000950170-24-077497
Chief Legal Officer sold 17,854 shares at $7.22 ($128,906)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sullivan Mark Chief Legal Officer | 2024-06-25 | Sale 10b5-1 | −17,854 | $7.22 | $128,906 | 182,146 | D |
| Open-market sales · 17,854 sh · avg $7.22 · $128,906 | |||||||
Loading xslF345X05/ownership.xml…